梅尔法兰
多发性骨髓瘤
自体干细胞移植
剂量
医学
移植
肿瘤科
内科学
作者
Zachary J. Brown,Scott Campbell,Li Fang Zhang,Ramses Sadek,Andrea Clarke,Anand Jillella,Amany R. Keruakous,Amber B. Clemmons
标识
DOI:10.1016/j.clml.2024.05.005
摘要
No standard criteria for dose reduction exists for high-dose melphalan for autologous stem cell transplantation (ASCT) for multiple myeloma (MM) due to limited and conflicting evidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI